Agilent, Incyte seek way to predict effectiveness of drugs

Betsy PriceBusiness, Headlines

Agilent Technologies and Incyte have begun working together to create tests that will help a patient understand how good a candidate he or she may be for Incyte’s immunotherapy treatments. Incyte, a biopharmaceutical company headquartered in Delaware, specializes in drugs that treat unusual and rare cancers. Agilent, headquartered in Santa Clara, California, with a campus near Greenville off Lancaster Pike, …